Zacks Research Has Optimistic Outlook of TriMas Q4 Earnings

TriMas Co. (NASDAQ:TRS) – Equities research analysts at Zacks Research upped their Q4 2024 earnings estimates for shares of TriMas in a research note issued on Monday, January 27th. Zacks Research analyst M. Das now expects that the industrial products company will earn $0.48 per share for the quarter, up from their prior estimate of $0.47. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q3 2025 earnings at $0.59 EPS, Q4 2026 earnings at $0.50 EPS and FY2026 earnings at $2.10 EPS.

TriMas (NASDAQ:TRS) last announced its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The business had revenue of $229.36 million during the quarter, compared to analysts’ expectations of $239.33 million. During the same period last year, the company earned $0.57 EPS. The firm’s revenue for the quarter was down 2.5% on a year-over-year basis.

Other equities analysts have also recently issued reports about the company. BWS Financial restated a “buy” rating and issued a $40.00 price objective on shares of TriMas in a research report on Thursday, January 23rd. StockNews.com raised shares of TriMas from a “sell” rating to a “hold” rating in a research note on Wednesday, November 13th.

TriMas Price Performance

TRS stock opened at $24.49 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The stock’s 50 day moving average price is $25.03 and its 200 day moving average price is $25.44. The firm has a market cap of $993.61 million, a P/E ratio of 38.27 and a beta of 0.67. TriMas has a 1 year low of $22.24 and a 1 year high of $28.51.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Algert Global LLC raised its position in shares of TriMas by 4.2% in the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock worth $403,000 after buying an additional 639 shares during the period. FMR LLC raised its holdings in shares of TriMas by 1.7% in the 3rd quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock worth $1,125,000 after purchasing an additional 729 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of TriMas by 3.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after purchasing an additional 1,227 shares in the last quarter. Inspire Investing LLC grew its holdings in shares of TriMas by 17.4% during the 3rd quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock worth $412,000 after purchasing an additional 2,389 shares during the period. Finally, Creative Planning increased its position in TriMas by 11.0% during the 2nd quarter. Creative Planning now owns 27,056 shares of the industrial products company’s stock worth $692,000 after purchasing an additional 2,681 shares in the last quarter. Institutional investors and hedge funds own 99.42% of the company’s stock.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.